The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Pattern Identified on fMRI May Rationalize Pain Research
April 15th 2013A series of studies using functional MRI have identified brain-signal patterns specific for pain that are attenuated by opioids: Also last week: top rheumatology findings of 2012, more on TNF inhibitors and cancer, and concerns about vitamin D.
Biologics Have Long Road Ahead to Reach FDA Approval in Pain Management
While digital medicine and neuromodulation have gathered enough clinical evidence to treat chronic pain, Timothy R. Deer, MD, president and CEO of St. Francis Hospital's Center for Pain Relief, in Charleston, WV, said regenerative therapies like platelet-rich plasma, stem cells and biologics are lagging years behind in the testing realm with a long road to go.
Trials Show Belimumab Boosts Quality of Life in Lupus
April 10th 2013The latest results from two late-stage, multicenter clinical trials of belimumab (Benlysta) show that, when given alongside standard therapy for systemic lupus erythematosus, the drug improves health-related quality of life (HRQOL) and fatigue.
Top 5 Mobile Apps for Rheumatologists
From full-motion video demonstrations of orthopedic clinical tests to suites of disease activity score calculators, these apps for Google and Apple mobile devices provide rheumatologists with useful and easy-to-access information at crucial moments in diagnosis and treatment.
Global Trials Affirms the Safety Profile of Adalimumab in RA and Other Inflammatory Diseases
April 4th 2013An analysis of adverse events in 17 global clinical trials of adalimumab (Humira) confirms the drug’s safety profile over nearly a dozen years of use for rheumatoid arthritis and other inflammatory disorders. Serious infections were the most common side effect.
Speedy Recovery Expected for Louisville Basketball Player's Open Tibia Fracture
One orthopedic surgeon estimates University of Louisville sophomore guard Kevin Ware will return to the basketball court after six months of healing and rehabilitation following emergency surgery on the athlete's compound fracture in his right tibia.
Of Hip Replacements, the Cost of Care and the Price of Cars
April 1st 2013New last week: Attempts to comparison shop for a total hip arthroplasty demonstrate the muddle in health care pricing. Also, a case study of an IV drug user who turned up with myalgias, arthritis, and pain, and a population-based link between glucocorticoids and pancreatitis.
Musculoskeletal Causes Now Top Disability Claims by a Large Margin
March 29th 2013Musculoskeletal diagnoses including back pain now top the list of disability claims in the US, up from a mere 8% in 1961 to nearly 34% in 2011. Whether a musculoskeletal claim is filed and accepted, according to a National Public Radio report, may be more a socioeconomic than medical issue.
Osteoarthritis as a Chronic Wound
March 26th 2013(AUDIO) Intensive analysis of protein pathways inside joints is showing strong activity among messengers involved in wound healing. In this podcast, learn about the new research that backs the vision of arthritis as a chronic wound, and the implications for management.
Obesity: A Mediator of Inflammation Complicating Knee Replacement
March 23rd 2013New research suggests that obesity is not merely a physical force on the knee joint; adipose cells contribute biochemically to inflammation and pain. What are the implications for management of obese patients who need knee replacement surgery?
No Evidence of Benefit Found for Arthroscopic Partial Meniscectomy
March 21st 2013The largest randomized controlled trial (RCT) so far has found no benefit to arthroscopic partial meniscectomy (APM) even in patients with symptomatic meniscal tears. An editorial advises against the procedure except when physical therapy has not helped at all.
The Microbiome and Autoimmunity: Seven Signs of Impending Paradigm Change
March 20th 2013We routinely treat disorders such as rheumatoid arthritis, lupus, scleroderma, and ankylosing spondylitis with immunosuppressive drugs. Yet if infection were known to be the root cause, this course of action would seem counterintuitive, if not potentially dangerous in the short or long run.
AAOS: Most With Massive Rotator Cuff Tears Can Avoid Surgery
March 19th 2013Conservative methods are good enough for 75% of patients with major rotator cuff tears, according to a single-center study reported at AAOS. As to those with shoulder arthritis, results of surgery are very good but not permanent.
Self-Reported Joint Pain Scores: Beyond RA, Key Information With Little Effort
March 11th 2013The RADAI joint index designed for rheumatoid arthritis patients provides equally powerful information about disease status in osteoarthritis and psoriatic arthritis, according to a new comparative study. As a guide to severity, it is much quicker than waiting for lab results to come in.
A New Marker of Silent Cardiovascular Disease in Diffuse Systemic Sclerosis
March 8th 2013More evidence of increased cardiovascular risk in patients with autoimmune and autoinflammatory diseases. A small controlled study finds increases in markers of early atherosclerosis in patients with systemic sclerosis.
Ultrasound Shows Inflammation in Late-Onset RA Missed by Disease Scores
March 7th 2013Elderly patients with late-onset rheumatoid arthritis (RA) have more inflammation in their joints than younger RA patients, even though their overall clinical disease activity (as measured by composite scores such as the Simplified Disease Activity Index or SDAI) does not appear different.